Insulin-like growth factor-I signaling in human neuroblastoma cells.
about
Mystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses Anchorage-independent growthMHC-restricted phosphopeptides from insulin receptor substrate-2 and CDC25b offer broad-based immunotherapeutic agents for cancer.An aging pathway controls the TrkA to p75NTR receptor switch and amyloid beta-peptide generationMotor protein-dependent membrane trafficking of KCl cotransporter-4 is important for cancer cell invasionPatterning N-type and S-type neuroblastoma cells with Pluronic F108 and ECM proteins.Insulin-like growth factor 1 stimulates KCl cotransport, which is necessary for invasion and proliferation of cervical cancer and ovarian cancer cells.Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma.Novel agents targeting the IGF-1R/PI3K pathway impair cell proliferation and survival in subsets of medulloblastoma and neuroblastoma.Aflatoxin B1 up-regulates insulin receptor substrate 2 and stimulates hepatoma cell migrationIntegrin expression regulates neuroblastoma attachment and migrationQuantitative phosphoproteomic analysis identifies activation of the RET and IGF-1R/IR signaling pathways in neuroblastoma.Sunitinib suppress neuroblastoma growth through degradation of MYCN and inhibition of angiogenesisSuppression of insulin receptor substrate 1 (IRS-1) promotes mammary tumor metastasis.AKT pathway in neuroblastoma and its therapeutic implication.A dual-specific anti-IGF-1/IGF-2 human monoclonal antibody alone and in combination with temsirolimus for therapy of neuroblastoma.Emerging treatment options for the treatment of neuroblastoma: potential role of perifosine.More than the genes, the tumor microenvironment in neuroblastoma.Mutual interaction and reciprocal down-regulation between c-met and insulin receptor substrate-1.Insulin receptor substrate (IRS)-2, not IRS-1, protects human neuroblastoma cells against apoptosis.IGF-1-induced processing of the amyloid precursor protein family is mediated by different signaling pathways.The role of insulin-like growth factor 1 and its receptor in the formation and development of colorectal carcinoma.IGF1;2:p-Y1161;1165;1166-IGF1R phosphorylates IRS1;2;4Association of IRS2 overexpression with disease progression in intrahepatic cholangiocarcinoma
P2860
Q24521364-FACA12E3-08D7-43FC-B5D6-BA48D5866123Q30303138-C93CAC4D-39CB-4139-9B6C-FA7B6F9FFA36Q30445022-9A76DBAD-8414-4E05-A28F-95FE6D5174F0Q33514783-8F1DFE25-F086-4112-B21E-21CC5CDEF75FQ33753911-A6616B4D-8D42-425B-B8D4-9E80F89F5DD0Q34334497-9B9BF580-A914-42A4-A459-C220C9DB906AQ34391785-79CD8DF5-D7A7-4FAC-8787-B5919F91BB65Q34442835-FB236258-590E-42C2-A4A3-33AF0CA0F6C3Q34462465-1B7D98DD-0957-40F6-8A59-BE38DCA023B1Q34770079-486BD436-C39A-4DD0-85FA-705713D8E3B9Q35070321-4323AD50-95ED-48FF-B50F-56D0D3FF489AQ35156047-013697EB-E640-4448-8CDB-ADA27C55E3DAQ35221417-89841C82-5229-4720-875E-44DBAEBF0E55Q37159523-DD72FA2D-9B3A-45E9-9809-E8D5F276EF88Q37162205-B5879D97-F9D9-48E5-8C86-5063364C09A5Q38474631-C9115E0E-C939-4773-9A21-F0AF173747A0Q38644731-AA0413A5-D4B2-4194-AF7A-A174ACEDF2E5Q39688384-78A267E5-B188-4389-AE1D-F470E0E4763DQ39877399-0C710FF1-AC2C-4BB6-81C0-530211B1B630Q40170952-56D07B3D-C8F4-4BB3-8B52-591D5B7877B9Q46086117-78C8668D-B6A6-4ABF-BE33-2F9FD7B948DCQ50298083-DC135CE7-401C-4A7B-A71C-10A419A22E09Q58794872-8D8C6633-9B15-4F07-A742-736B833CD1F0
P2860
Insulin-like growth factor-I signaling in human neuroblastoma cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Insulin-like growth factor-I signaling in human neuroblastoma cells.
@en
type
label
Insulin-like growth factor-I signaling in human neuroblastoma cells.
@en
prefLabel
Insulin-like growth factor-I signaling in human neuroblastoma cells.
@en
P2860
P356
P1433
P1476
Insulin-like growth factor-I signaling in human neuroblastoma cells
@en
P2093
Bhumsoo Kim
Cynthia M van Golen
P2860
P2888
P304
P356
10.1038/SJ.ONC.1206924
P407
P577
2004-01-01T00:00:00Z
P5875
P6179
1031223985